Patents by Inventor Kuei-Hung Lai

Kuei-Hung Lai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 9,11-SECOSTEROIDS AND THE USE OF 9,11-SECOSTEROIDS IN PREPARING PHARMACEUTICAL COMPOSITIONS FOR INHIBITING INFLAMMATION
    Publication number: 20220040199
    Abstract: A method for inhibiting inflammatory in a subject is provided, comprising: administering a pharmaceutical composition comprising an effective amount of 9,11-secosteroids.
    Type: Application
    Filed: April 28, 2021
    Publication date: February 10, 2022
    Applicant: Chang Gung University of Science and Technology
    Inventors: Tsong-Long Hwang, Yu-Chia Chang, Kuei-Hung Lai
  • Scalarane sesterterpenoid, pharmaceutical composition and topoisomerase II and Hsp90 inhibitor for treating cancer, and use and preparation method thereof
    Patent number: 10314847
    Abstract: The present invention discloses scalarane sesterterpenoids represented by formula (I) and meroditerpenoid represented by formula (II), which are extracted from Carteriospongia sp. sponge: where R1 is —CH3 or —C2H5. The compounds of formula (I) can be used to be an anticancer, act as an inhibitor targeting to topoisomerase II and hsp90 and a pharmaceutical composition for anticancer.
    Type: Grant
    Filed: August 14, 2017
    Date of Patent: June 11, 2019
    Assignee: National Dong Hwa University
    Inventors: Mei-Chin Lu, Ping-Jyun Sung, Jui-Hsin Su, Kuei-Hung Lai, Yi-Chang Liu, Ying-Chi Du, Yu-Ming Hsu, Ming-Kai Weng, Fu-Wen Kuo
  • SCALARANE SESTERTERPENOID, PHARMACEUTICAL COMPOSITION AND TOPOISOMERASE II AND Hsp90 INHIBITOR FOR TREATING CANCER, AND USE AND PREPARATION METHOD THEREOF
    Publication number: 20180271879
    Abstract: The present invention discloses scalarane sesterterpenoids represented by formula (I) and meroditerpenoid represented by formula (II), which are extracted from Carteriospongia sp. sponge: where R1 is —CH3 or —C2H5. The compounds of formula (I) can be used to be an anticancer, act as an inhibitor targeting to topoisomerase II and hsp90 and a pharmaceutical composition for anticancer.
    Type: Application
    Filed: August 14, 2017
    Publication date: September 27, 2018
    Applicant: NATIONAL DONG HWA UNIVERSITY
    Inventors: Mei-Chin Lu, Ping-Jyun Sung, Jui-Hsin Su, Kuei-Hung Lai, Yi-Chang Liu, Ying-Chi Du, Yu-Ming Hsu, Ming-Kai Weng, Fu-Wen Kuo